TOVX – theriva biologics, inc. (US:NASDAQ)
Stock Stats
News
Theriva™ Biologics to Discuss the Trial Design for VIRAGE - a Phase 2b Clinical Study of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma - at the 2024 American Society of Clinical Oncology (ASCO) Annua
Theriva™ Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
Theriva™ Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting
Medical Foods: Global Industry Review 2018-2023 and Forecast 2024-2033 - Integration of Digital Technologies for Personalized Nutrition Presents Lucrative Growth Opportunities [Yahoo! Finance]
Form 8-K Theriva Biologics, Inc. For: Apr 23
Form 8-K Theriva Biologics, Inc. For: Apr 22
Form 8-K Theriva Biologics, Inc. For: Apr 16
Form 10-K Theriva Biologics, Inc. For: Dec 31
Form 8-K Theriva Biologics, Inc. For: Mar 25
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.